Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
Finasteride is primarily used to treat benign prostatic hyperplasia (BPH) and male androgenetic alopecia (MAA). Five-alpha reductase inhibitors (5α-RIs) could induce male sexual dysfunction due to their effects on testosterone and dihydrotestos-terone. There is evidence suggesting that 5α-RIs may in...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society for Sexual Medicine and Andrology
2019-05-01
|
Series: | The World Journal of Men's Health |
Subjects: |
_version_ | 1811344987341717504 |
---|---|
author | Yu Seob Shin Keshab Kumar Karna Bo Ram Choi Jong Kwan Park |
author_facet | Yu Seob Shin Keshab Kumar Karna Bo Ram Choi Jong Kwan Park |
author_sort | Yu Seob Shin |
collection | DOAJ |
description | Finasteride is primarily used to treat benign prostatic hyperplasia (BPH) and male androgenetic alopecia (MAA). Five-alpha reductase inhibitors (5α-RIs) could induce male sexual dysfunction due to their effects on testosterone and dihydrotestos-terone. There is evidence suggesting that 5α-RIs may independently increase the risk of erectile dysfunction (ED). However, many investigators believe that side effects of 5α-RIs will disappear with continuous treatment. Considerable controversy exists regarding the severity and persistence of side effects of finasteride on ED. The aim of this review was to summarize current research studies on finasteride associated with ED. The search strategy used each term of finasteride and ED against PubMed database to identify related studies. ED data reported from available trials for finasteride were summarized and reviewed. Although there is not enough evidence to prove the relationship between finasteride and ED, most studies in this review found that finasteride for BPH was correlated with ED. However, most studies included in this review revealed that finasteride for MAA was not correlated with ED. On the other hand, some studies reported side effects of finasteride associ-ated with sexual dysfunction, including ED, male infertility, ejaculation problem, and loss of libido, even in MAA patients. Well-designed randomized controlled trials are needed to further determine the mechanism and effects of finasteride on ED. However, physicians should discuss with their patients possible long-term effects of finasteride on sexual function, although we do not have evidence showing that adverse events of sexual dysfunction are absolutely associated with 5α-RIs. |
first_indexed | 2024-04-13T19:56:20Z |
format | Article |
id | doaj.art-527e74f7b2154d0ca5350daf270bc6fa |
institution | Directory Open Access Journal |
issn | 2287-4208 2287-4690 |
language | English |
last_indexed | 2024-04-13T19:56:20Z |
publishDate | 2019-05-01 |
publisher | Korean Society for Sexual Medicine and Andrology |
record_format | Article |
series | The World Journal of Men's Health |
spelling | doaj.art-527e74f7b2154d0ca5350daf270bc6fa2022-12-22T02:32:20ZengKorean Society for Sexual Medicine and AndrologyThe World Journal of Men's Health2287-42082287-46902019-05-0137215716510.5534/wjmh.180029Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic AlopeciaYu Seob Shin0Keshab Kumar Karna1Bo Ram Choi2Jong Kwan Park3Department of Urology, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute and Clinical Trial Center of Medical Device of Chonbuk National University Hospital, Jeonju, KoreaDepartment of Urology, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute and Clinical Trial Center of Medical Device of Chonbuk National University Hospital, Jeonju, KoreaDepartment of Urology, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute and Clinical Trial Center of Medical Device of Chonbuk National University Hospital, Jeonju, KoreaDepartment of Urology, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute and Clinical Trial Center of Medical Device of Chonbuk National University Hospital, Jeonju, KoreaFinasteride is primarily used to treat benign prostatic hyperplasia (BPH) and male androgenetic alopecia (MAA). Five-alpha reductase inhibitors (5α-RIs) could induce male sexual dysfunction due to their effects on testosterone and dihydrotestos-terone. There is evidence suggesting that 5α-RIs may independently increase the risk of erectile dysfunction (ED). However, many investigators believe that side effects of 5α-RIs will disappear with continuous treatment. Considerable controversy exists regarding the severity and persistence of side effects of finasteride on ED. The aim of this review was to summarize current research studies on finasteride associated with ED. The search strategy used each term of finasteride and ED against PubMed database to identify related studies. ED data reported from available trials for finasteride were summarized and reviewed. Although there is not enough evidence to prove the relationship between finasteride and ED, most studies in this review found that finasteride for BPH was correlated with ED. However, most studies included in this review revealed that finasteride for MAA was not correlated with ED. On the other hand, some studies reported side effects of finasteride associ-ated with sexual dysfunction, including ED, male infertility, ejaculation problem, and loss of libido, even in MAA patients. Well-designed randomized controlled trials are needed to further determine the mechanism and effects of finasteride on ED. However, physicians should discuss with their patients possible long-term effects of finasteride on sexual function, although we do not have evidence showing that adverse events of sexual dysfunction are absolutely associated with 5α-RIs.AlopeciaErectile dysfunctionFinasterideProstatic hyperplasia |
spellingShingle | Yu Seob Shin Keshab Kumar Karna Bo Ram Choi Jong Kwan Park Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia The World Journal of Men's Health Alopecia Erectile dysfunction Finasteride Prostatic hyperplasia |
title | Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia |
title_full | Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia |
title_fullStr | Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia |
title_full_unstemmed | Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia |
title_short | Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia |
title_sort | finasteride and erectile dysfunction in patients with benign prostatic hyperplasia or male androgenetic alopecia |
topic | Alopecia Erectile dysfunction Finasteride Prostatic hyperplasia |
work_keys_str_mv | AT yuseobshin finasterideanderectiledysfunctioninpatientswithbenignprostatichyperplasiaormaleandrogeneticalopecia AT keshabkumarkarna finasterideanderectiledysfunctioninpatientswithbenignprostatichyperplasiaormaleandrogeneticalopecia AT boramchoi finasterideanderectiledysfunctioninpatientswithbenignprostatichyperplasiaormaleandrogeneticalopecia AT jongkwanpark finasterideanderectiledysfunctioninpatientswithbenignprostatichyperplasiaormaleandrogeneticalopecia |